AQR Capital Management - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 172 filers reported holding CARA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,086,772
+579.2%
646,888
+3602.9%
0.00%
Q2 2022$160,000
-69.3%
17,470
-59.3%
0.00%
-100.0%
Q1 2022$522,000
-63.7%
42,956
-63.6%
0.00%
-66.7%
Q4 2021$1,438,000
+228.3%
118,100
+316.4%
0.00%
+200.0%
Q3 2021$438,000
-33.9%
28,362
-39.0%
0.00%0.0%
Q2 2021$663,000
+204.1%
46,485
+363.9%
0.00%
Q1 2021$218,000
-3.5%
10,020
-28.7%
0.00%
Q4 2019$226,000
-16.6%
14,056
-5.2%
0.00%
Q3 2019$271,000
+17.3%
14,826
+38.0%
0.00%
Q2 2019$231,000
+68.6%
10,745
+1.9%
0.00%
Q4 2018$137,000
-34.1%
10,541
-37.3%
0.00%
Q1 2018$208,000
-45.7%
16,817
-46.3%
0.00%
Q4 2017$383,000
-35.7%
31,305
-28.2%
0.00%
-100.0%
Q3 2017$596,000
-17.8%
43,570
-7.5%
0.00%0.0%
Q2 2017$725,000
+104.2%
47,085
+143.6%
0.00%
Q1 2017$355,000
+1.7%
19,329
-53.8%
0.00%
-100.0%
Q3 2016$349,000
-53.8%
41,858
-73.3%
0.00%0.0%
Q2 2016$755,000
-3.1%
157,057
+25.4%
0.00%0.0%
Q1 2016$779,000
-58.5%
125,291
+12.4%
0.00%
-66.7%
Q4 2015$1,878,000
+72.8%
111,428
+46.4%
0.00%
+50.0%
Q3 2015$1,087,000
+451.8%
76,093
+368.9%
0.00%
Q2 2015$197,00016,2280.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 2,799,058$42,350,00022.29%
Chescapmanager LLC 1,314,603$19,890,0002.42%
Prosight Management, LP 294,041$4,449,0002.06%
DAFNA Capital Management LLC 261,442$3,956,0001.18%
Cypress Capital Management LLC (WY) 81,269$1,230,0001.06%
KINGDON CAPITAL MANAGEMENT, L.L.C. 626,583$9,480,0001.02%
Carmignac Gestion 1,851,443$28,012,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 2,465,000$37,295,0000.22%
Ikarian Capital, LLC 301,700$4,565,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 689,899$10,438,0000.20%
View complete list of CARA THERAPEUTICS INC shareholders